Gold Standard:Pathological diagnosis, Clinical outcome

3 trials

Sponsors

The First Affiliated Hospital of Zhengzhou University, The Second Affiliated Hospital of Nanchang University, The Third Affiliated Hospital of Navy Military Medical University

Conditions

esophagus cancerhepatic cancerhepatocelluar carcinoma

Unknown Phase

The value of 18F-ML-10 PET/CT imaging to evaluate the early response after radiotherapy in esophagus cancer

Active, not recruitingChiCTR1800018062

The First Affiliated Hospital of Zhengzhou Universityesophagus cancer

Start: 2018-08-28Updated: 2018-09-03

Clinical application of exosomal DNA as a ''liquid biopsy'' marker for whole-process monitoring of liver cancer

RecruitingChiCTR2100054275

The Second Affiliated Hospital of Nanchang Universityhepatic cancer

Start: 2022-01-01Updated: 2022-11-14

Application research of 3D reconstruction technology in predicting the pathological invasion and surgical prognosis of liver cancer

RecruitingChiCTR2300070567

The Third Affiliated Hospital of Navy Military Medical Universityhepatocelluar carcinoma

Start: 2023-04-06Updated: 2023-06-04